Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Biosearch Announces Acquisition of European Companies DNA Technology and VitraBio

Published: Tuesday, July 23, 2013
Last Updated: Tuesday, July 23, 2013
Bookmark and Share
Acquisition marks Company’s increasing commitment to support European biotechnology and diagnostic markets.

Biosearch Technologies, Inc. (Biosearch) has announced that it has acquired the oligonucleotide manufacturing division of the Danish company DNA Technology A/S (DNA Technology) and German CPG manufacturer VitraBio GmbH (VitraBio).

With the acquisition of DNA Technology, Biosearch has added a highly skilled production team with a mature quality system and an established European customer base focused in the Nordic countries.

DNA Technology specializes in production of modified oligos, and will benefit from full access to the breadth of specialty modifications produced by Biosearch.

In addition, Biosearch will provide manufacturing tools and access to its substantial IP portfolio enabling DNA Technology to expand production capabilities and product offerings in order to better serve an expanding customer base.

With the acquisition of German controlled-pore glass (CPG) manufacturer VitraBio in September 2011, Biosearch gains control over VitraBio’s sophisticated CPG manufacturing technology and unique production facility, which expands its already extensive repertoire of oligo synthesis tools and processes.

In addition to continuing production of DNA/RNA synthesis supports for the research and therapeutic oligo markets, Biosearch intends to bring chemical manufacturing capabilities to VitraBio’s Steinach facility to supplement existing US production of specialty amidites and modified CPGs.

The acquisition of DNA Technology and VitraBio marks Biosearch’s increasing commitment to support European biotechnology and diagnostic markets.

Furthermore, Biosearch has secured important manufacturing redundancy for its North American operations as well as a strong base from which to grow sales, production and regulated contract manufacturing capabilities throughout Europe.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biosearch Technologies Awarded Phase II Army SBIR Grant
The $800,000+ Phase II grant is aimed to back the design and development of rapid and accurate assays for pathogens of military importance.
Thursday, September 23, 2010
Scientific News
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
New Treatment for Immune Cancers
Clinical trial shows new drug holds promise for treating advanced mastocytosis.
Sickle Cell Gene Therapy Passes Test
Researchers found a precision-engineered gene therapy virus reduced sickle-induced red-cell damage in mice with sickle cell disease.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Vitamin C May Boost Leukemia Treatment
Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.
Inovio Launches Zika Vaccine Trial
Inovio launches Zika vaccine trial in midst of Puerto Rico epidemic to explore early signals of vaccine efficacy.
New Hope for Zika Treatment Found in Large-Scale Screen of Existing Drugs
Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection
FINCH Filgotinib Phase 3 Program Initiated
Galapagos NV reports the initiation of the FINCH global Phase 3 program in rheumatoid arthritis patient populations.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!